Previous studies have demonstrated the feasibility of 11C-erlotinib PET imaging in healthy volunteers [15], which may be combined with rifampicin administration [39]
Previous studies have demonstrated the feasibility of 11C-erlotinib PET imaging in healthy volunteers [15], which may be combined with rifampicin […]